Zogenix to Release Third Quarter 2015 Financial Results and Host Conference Call & Webcast on November 9
Get Alerts ZGNX Hot Sheet
Join SI Premium – FREE
SAN DIEGO, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the third quarter ended September 30, 2015 after the market close, and will host a corporate update conference call and webcast on Monday, November 9, 2015, at 4:30pm Eastern Time.
Monday, November 9th @ 4:30pm Eastern Time/1:30pm Pacific Time | |
Toll Free: | 888-523-1228 |
International: | 719-325-2308 |
Conference ID: | 660434 |
Webcast: | http://public.viavid.com/player/index.php?id=116611 |
Replays, available through November 23, 2015: | |
Domestic: | 877-870-5176 |
International: | 858-384-5517 |
Conference ID: | 660434 |
About Zogenix
Zogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.
For more information, visit www.zogenix.com.
CONTACT: Investors: Andrew McDonald Founding Partner, LifeSci Advisors LLC 646-597-6987 | [email protected]Source: Zogenix, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- St. Joe Company (JOE) Reports Q1 EPS of $0.24
- Oceaneering (OII) Tops Q1 EPS by 5c, confirms prior guidance
- Ball Corporation (BALL) Raises Dividend, Enters 40M Share Buyback, Announces Management Changes
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!